HCAT - Health Catalyst, Inc.

QQQ $ 450.33 $ -2.39 (-0.53 %)

DIA $ 398.88 $ -0.24 (-0.06 %)

SPY $ 527.97 $ -0.96 (-0.18 %)

TLT $ 91.44 $ -0.18 (-0.2 %)

GLD $ 223.83 $ 1.59 (0.72 %)

Previous Close

$ 7.03

Open

$ 6.97

Bid

$ 6.10 x 350

Ask

$ 0.00 x 0

Day's Range

$ 6.85 - $ 6.98

52 Week Range

$ 5.45 - $ 14.37

Volume

519,564

Average Volume

Market Cap

411.9M

Beta (5Y Monthly)

$ 1.13

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-06-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-12-2020	06-30-2020	10-Q
17	05-13-2020	03-31-2020	10-Q
18	02-28-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-23-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wells Fargo Maintains Overweight on Health...
05/10/2024 15:50:18

Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target f...

Health Catalyst Sees FY24 Revenue $304.0M-...
05/09/2024 21:10:57

Health Catalyst Sees Q2 2024 Revenue $73.5...
05/09/2024 21:10:47

Health Catalyst Q1 2024 Adj EPS $0.05 Beat...
05/09/2024 20:30:49

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03...

What 7 Analyst Ratings Have To Say About H...
04/10/2024 15:00:22

Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 14:16:30

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Overweight and maintains $16 price tar...

SMART Global Reports Q2 Results, Joins Hea...
04/10/2024 09:57:26

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining by around 0.1% on Wednesday.

Keybanc Downgrades Health Catalyst to Sect...
04/10/2024 08:44:23

Keybanc analyst Scott Schoenhaus downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Sector Weight.

Cantor Fitzgerald Reiterates Overweight on...
03/05/2024 17:37:15

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Overweight and maintains $16 price tar...

Keybanc Maintains Overweight on Health Cat...
02/26/2024 10:19:51

Keybanc analyst Scott Schoenhaus maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from ...

Analyst Scoreboard: 5 Ratings For Health C...
02/23/2024 15:00:54

Canaccord Genuity Maintains Buy on Health ...
02/23/2024 14:44:24

Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from ...

Health Catalyst Sees FY24 Revenue $304M-$3...
02/22/2024 21:39:50

Health Catalyst Sees Q1 2024 Revenue $72.5...
02/22/2024 21:39:37

Health Catalyst Q4 2023 GAAP EPS $0.02, Sa...
02/22/2024 21:15:54

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.02 per share. The company reported quarterly sales of $75.08 m...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Health Catalyst's MeasureAble Earns ONC He...
02/21/2024 13:12:43

Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and se...

Demystifying Health Catalyst: Insights Fro...
01/26/2024 13:00:30

Guggenheim Upgrades Health Catalyst to Buy...
01/26/2024 10:31:33

Guggenheim analyst Jack Wallace upgrades Health Catalyst (NASDAQ:HCAT) from Neutral to Buy and announces $14 price target.

Health Catalyst, Inc. Announces Preliminar...
01/08/2024 21:06:52